These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

257 related items for PubMed ID: 11196168

  • 1. A novel role of metalloproteinase in cancer-mediated immunosuppression.
    Sheu BC, Hsu SM, Ho HN, Lien HC, Huang SC, Lin RH.
    Cancer Res; 2001 Jan 01; 61(1):237-42. PubMed ID: 11196168
    [Abstract] [Full Text] [Related]

  • 2. Up-regulation of inhibitory natural killer receptors CD94/NKG2A with suppressed intracellular perforin expression of tumor-infiltrating CD8+ T lymphocytes in human cervical carcinoma.
    Sheu BC, Chiou SH, Lin HH, Chow SN, Huang SC, Ho HN, Hsu SM.
    Cancer Res; 2005 Apr 01; 65(7):2921-9. PubMed ID: 15805295
    [Abstract] [Full Text] [Related]

  • 3. Tumor-infiltrating lymphocytes contain higher numbers of type 1 cytokine expressors and DR+ T cells compared with lymphocytes from tumor draining lymph nodes and peripheral blood in patients with cancer of the uterine cervix.
    Santin AD, Ravaggi A, Bellone S, Pecorelli S, Cannon M, Parham GP, Hermonat PL.
    Gynecol Oncol; 2001 Jun 01; 81(3):424-32. PubMed ID: 11371133
    [Abstract] [Full Text] [Related]

  • 4. Early immune response and regulation of IL-2 receptor subunits.
    Hughes-Fulford M, Sugano E, Schopper T, Li CF, Boonyaratanakornkit JB, Cogoli A.
    Cell Signal; 2005 Sep 01; 17(9):1111-24. PubMed ID: 15993752
    [Abstract] [Full Text] [Related]

  • 5. Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer.
    Woo EY, Chu CS, Goletz TJ, Schlienger K, Yeh H, Coukos G, Rubin SC, Kaiser LR, June CH.
    Cancer Res; 2001 Jun 15; 61(12):4766-72. PubMed ID: 11406550
    [Abstract] [Full Text] [Related]

  • 6. Mechanisms of Trypanosoma cruzi-induced down-regulation of lymphocyte function. Inhibition of transcription and expression of IL-2 receptor gamma (p64IL-2R) and beta (p70IL-2R) chain molecules in activated normal human lymphocytes.
    Majumder S, Kierszenbaum F.
    J Immunol; 1996 May 15; 156(10):3866-74. PubMed ID: 8621925
    [Abstract] [Full Text] [Related]

  • 7. Evidence that cervical cancer cells secrete IL-2, which becomes an autocrine growth factor.
    Rangel-Corona R, Corona-Ortega T, Soto-Cruz I, López-Labra A, Pablo-Arcos T, Torres-Guarneros CF, Weiss-Steider B.
    Cytokine; 2010 Jun 15; 50(3):273-7. PubMed ID: 20227890
    [Abstract] [Full Text] [Related]

  • 8. Spontaneous expression of the interleukin 2 receptor gene and presence of functional interleukin 2 receptors on T lymphocytes in the blood of individuals with active pulmonary sarcoidosis.
    Konishi K, Moller DR, Saltini C, Kirby M, Crystal RG.
    J Clin Invest; 1988 Sep 15; 82(3):775-81. PubMed ID: 3138285
    [Abstract] [Full Text] [Related]

  • 9. The in vitro effect on T cell function of soluble IL-2Ralpha from advanced ovarian cancer ascites.
    Elg SA, Hill RB, Heldman L, Ramakrishnan S.
    Gynecol Oncol; 1997 Jul 15; 66(1):133-7. PubMed ID: 9234933
    [Abstract] [Full Text] [Related]

  • 10. Lack of IL-2 cytokine expression despite Il-2 messenger RNA transcription in tumor-infiltrating lymphocytes in primary human breast carcinoma: selective expression of early activation markers.
    Coventry BJ, Weeks SC, Heckford SE, Sykes PJ, Bradley J, Skinner JM.
    J Immunol; 1996 May 01; 156(9):3486-92. PubMed ID: 8617977
    [Abstract] [Full Text] [Related]

  • 11. Nonantigen specific CD8+ T suppressor lymphocytes originate from CD8+CD28- T cells and inhibit both T-cell proliferation and CTL function.
    Filaci G, Fravega M, Negrini S, Procopio F, Fenoglio D, Rizzi M, Brenci S, Contini P, Olive D, Ghio M, Setti M, Accolla RS, Puppo F, Indiveri F.
    Hum Immunol; 2004 Feb 01; 65(2):142-56. PubMed ID: 14969769
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-2-dependent autocrine proliferation in T-cell development.
    Toribio ML, Gutiérrez-Ramos JC, Pezzi L, Marcos MA, Martínez C.
    Nature; 1989 Nov 02; 342(6245):82-5. PubMed ID: 2812004
    [Abstract] [Full Text] [Related]

  • 13. The lack of epithelial interleukin-7 and BAFF/BLyS gene expression in prostate cancer as a possible mechanism of tumor escape from immunosurveillance.
    Di Carlo E, D'Antuono T, Pompa P, Giuliani R, Rosini S, Stuppia L, Musiani P, Sorrentino C.
    Clin Cancer Res; 2009 May 01; 15(9):2979-87. PubMed ID: 19366834
    [Abstract] [Full Text] [Related]

  • 14. Regulation of interleukin-2 and interleukin-4 receptor expression in human and ape lymphoid cell lines.
    Guizani L, Lang P, Stancou R, Bertoglio J.
    Lymphokine Cytokine Res; 1993 Feb 01; 12(1):25-32. PubMed ID: 8457629
    [Abstract] [Full Text] [Related]

  • 15. CD28 costimulation up-regulates long-term IL-2R beta expression in human T cells through combined transcriptional and post-transcriptional regulation.
    Cerdan C, Martin Y, Courcoul M, Mawas C, Birg F, Olive D.
    J Immunol; 1995 Feb 01; 154(3):1007-13. PubMed ID: 7822778
    [Abstract] [Full Text] [Related]

  • 16. Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers.
    Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H.
    Clin Cancer Res; 2003 Oct 01; 9(12):4404-8. PubMed ID: 14555512
    [Abstract] [Full Text] [Related]

  • 17. Down-regulation of KOLT-2 antigen (CD28) by interleukin 2; role of IL-2R (p70).
    Shindo T, Sugie K, Nakamura K, Tagaya Y, Maeda M, Uchiyama T, Sagawa K, Yokoyama M, Wada H, Hitomi S.
    Immunology; 1990 Sep 01; 71(1):63-9. PubMed ID: 2170270
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.